Cryoport, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -7.1%
EBITDA: +90.7%
EBIT: +66.7%
EPS: +161.1%
Free cash flow: +29.2%
Operating cash flow: +97.1%

Forward estimates

Revenue: +8.7%
EBITDA: —
EPS: —

Three-year CAGR

Revenue: -7.5%
EBITDA: +96.8%
EBIT: +68.0%
Net income: +178.6%
EPS: +163.3%
Free cash flow: +16.4%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.